Star Sports Medicine Co., Ltd Class (1609.HK) Comparison with companies in other sectors?

Star Sports Medicine Co., Ltd Class has a share price of 8.42M. You can analyze Star Sports Medicine Co., Ltd Class (1609.HK) competitors across different market sectors through stock heatmaps.

What are 1609.HK's NET and operating margins?

Star Sports Medicine Co., Ltd Class (1609.HK) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does 1609.HK's earnings per share (EPS) trend reflect its financial momentum?

Star Sports Medicine Co., Ltd Class (1609.HK) EPS is 2.89 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Star Sports Medicine Co., Ltd Class is 66.57, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Star Sports Medicine Co., Ltd Class?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Star Sports Medicine Co., Ltd Class like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Star Sports Medicine Co., Ltd Class Fundamental Analysis

1609.HK●HKSE

IndustrialsEngineering & Construction

HK$187.00

HK$6.40(3.31%)

Hong Kong Market opens in 14h 34m

Star Sports Medicine Co., Ltd Class Fundamental Analysis

Star Sports Medicine Co., Ltd Class (1609.HK) shows weak financial fundamentals with a PE ratio of 66.57, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze 1609.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze 1609.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

1609.HK struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

1609.HK trades at a premium to fair value.

PE < 25

66.57

PEG Ratio < 2

N/A

Growth Score

Moderate

1609.HK shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

1609.HK carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

1609.HK struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is 1609.HK Expensive or Cheap?

P/E Ratio

1609.HK trades at 66.57 times earnings. This suggests a premium valuation.

66.57

How Well Does 1609.HK Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How 1609.HK Stacks Against Its Sector Peers

Metric	1609.HK Value	Sector Average	Performance
P/E Ratio	N/A	34.08	N/A
ROE	N/A	1170.00%	N/A
Net Margin	N/A	-29035.00% (disorted)	N/A
Debt/Equity	N/A	0.75	N/A
Current Ratio	N/A	29.13	N/A
ROA	N/A	-1358223.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Star Sports Medicine Co., Ltd Class's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

EPS CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

FCF CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

Star Sports Medicine Co., Ltd Class Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is 1609.HK Expensive or Cheap?

How Well Does 1609.HK Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How 1609.HK Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Star Sports Medicine Co., Ltd Class (1609.HK) Comparison with companies in other sectors?

What are 1609.HK's NET and operating margins?

In what way does 1609.HK's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Star Sports Medicine Co., Ltd Class?

How do I know if AAPL is overvalued or undervalued?